[go: up one dir, main page]

WO1990015568A3 - Appareil et methodes pour le controle non-invasif du glucose dans le sang - Google Patents

Appareil et methodes pour le controle non-invasif du glucose dans le sang

Info

Publication number
WO1990015568A3
WO1990015568A3 PCT/US1990/002940 US9002940W WO9015568A3 WO 1990015568 A3 WO1990015568 A3 WO 1990015568A3 US 9002940 W US9002940 W US 9002940W WO 9015568 A3 WO9015568 A3 WO 9015568A3
Authority
WO
WIPO (PCT)
Prior art keywords
glucose
receiving medium
membrane
medium
receiving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1990/002940
Other languages
English (en)
Other versions
WO1990015568A2 (fr
Inventor
Theodore H Stanley
Charles Dewey Ebert
William I Higuchi
Jie Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to KR1019910700129A priority Critical patent/KR920700014A/ko
Publication of WO1990015568A2 publication Critical patent/WO1990015568A2/fr
Publication of WO1990015568A3 publication Critical patent/WO1990015568A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/14—Devices for taking samples of blood ; Measuring characteristics of blood in vivo, e.g. gas concentration within the blood, pH-value of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Optics & Photonics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Sampling And Sample Adjustment (AREA)

Abstract

La présente invention décrit de nouvelles méthodes et un nouvel appareil pour le contrôle non invasif du glucose dans le sang. Ce contrôle s'effectue par corrélation avec le taux de glucose qui imprègne une membrane épithéliale (14), peau ou muqueuse, dans un récepteur du glucose (12), sur une période donnée. Le récepteur (12) comprend de préférence un stimulateur d'imprégnation du glucose capable d'augmenter la perméabilité du glucose à travers la membrane épithéliale (14). Le récepteur (12) est placé contre ladite membrane (14), de sorte que le stimulateur d'imprégnation en modifie la perméabilité. Passé un laps de temps suffisant, le récepteur du glucose (12) est enlevé et soumis à analyse pour la recherche de glucose suivant les techniques traditionnelles. L'appareil comprend un dispositif qui sert de support au récepteur du glucose. Ce dispositif peut se composer d'un cadre (18) définissant une chambre réceptrice qui maintient le récepteur (12) et d'une ouverture sur cette chambre. Le dispositif peut aussi inclure un hydrogel. L'appareil comprend aussi de préférence un dispositif (20) servant à positionner temporairement le récepteur du glucose contre la membrane épithéliale.
PCT/US1990/002940 1989-06-02 1990-05-24 Appareil et methodes pour le controle non-invasif du glucose dans le sang Ceased WO1990015568A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019910700129A KR920700014A (ko) 1989-06-02 1990-05-24 비침입적인 혈중 글루코오스의 검사 장치 및 방법

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36036089A 1989-06-02 1989-06-02
US360,360 1989-06-02

Publications (2)

Publication Number Publication Date
WO1990015568A2 WO1990015568A2 (fr) 1990-12-27
WO1990015568A3 true WO1990015568A3 (fr) 1991-04-18

Family

ID=23417658

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1990/002940 Ceased WO1990015568A2 (fr) 1989-06-02 1990-05-24 Appareil et methodes pour le controle non-invasif du glucose dans le sang

Country Status (3)

Country Link
KR (1) KR920700014A (fr)
AU (1) AU5825490A (fr)
WO (1) WO1990015568A2 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7066884B2 (en) 1998-01-08 2006-06-27 Sontra Medical, Inc. System, method, and device for non-invasive body fluid sampling and analysis
US7432069B2 (en) 2005-12-05 2008-10-07 Sontra Medical Corporation Biocompatible chemically crosslinked hydrogels for glucose sensing
US8870810B2 (en) 1998-12-18 2014-10-28 Echo Therapeutics, Inc. Method and apparatus for enhancement of transdermal transport
US9572527B2 (en) 2007-04-27 2017-02-21 Echo Therapeutics, Inc. Skin permeation device for analyte sensing or transdermal drug delivery

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6041253A (en) * 1995-12-18 2000-03-21 Massachusetts Institute Of Technology Effect of electric field and ultrasound for transdermal drug delivery
JP2002515786A (ja) 1996-06-28 2002-05-28 ソントラ メディカル，エル．ピー． 経皮輸送の超音波増強
US6602678B2 (en) * 1998-09-04 2003-08-05 Powderject Research Limited Non- or minimally invasive monitoring methods
AU6035299A (en) * 1998-09-09 2000-03-27 Amira Medical Interstitial fluid methods and devices for determination of an analyte in the body
US6251083B1 (en) 1999-09-07 2001-06-26 Amira Medical Interstitial fluid methods and devices for determination of an analyte in the body
US20040010185A1 (en) * 2002-07-11 2004-01-15 Optical Sensors, Inc. Method for measuring a physiologic parameter using a preferred site
WO2023172192A2 (fr) * 2022-03-08 2023-09-14 Agency For Science, Technology And Research Biocapteur épidermique

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4250163A (en) * 1979-03-05 1981-02-10 Teijin Limited Method and preparation for administration to the mucosa of the oral or nasal cavity
US4321252A (en) * 1979-08-14 1982-03-23 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing ester derivatives of estradiol
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
WO1986000536A1 (fr) * 1984-07-06 1986-01-30 Avery International Corporation Pansement pour la liberation entretenue de medicaments
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
US4819645A (en) * 1985-02-11 1989-04-11 The United States Of America As Represented By The Secretary Of The Army Dermal substance collection method
US4889721A (en) * 1987-07-24 1989-12-26 Fujisawa Pharmaceutical Co., Ltd. Sustained-release percutaneous preparations

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4250163A (en) * 1979-03-05 1981-02-10 Teijin Limited Method and preparation for administration to the mucosa of the oral or nasal cavity
US4321252A (en) * 1979-08-14 1982-03-23 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing ester derivatives of estradiol
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
WO1986000536A1 (fr) * 1984-07-06 1986-01-30 Avery International Corporation Pansement pour la liberation entretenue de medicaments
US4819645A (en) * 1985-02-11 1989-04-11 The United States Of America As Represented By The Secretary Of The Army Dermal substance collection method
US4889721A (en) * 1987-07-24 1989-12-26 Fujisawa Pharmaceutical Co., Ltd. Sustained-release percutaneous preparations

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7066884B2 (en) 1998-01-08 2006-06-27 Sontra Medical, Inc. System, method, and device for non-invasive body fluid sampling and analysis
US8870810B2 (en) 1998-12-18 2014-10-28 Echo Therapeutics, Inc. Method and apparatus for enhancement of transdermal transport
US7432069B2 (en) 2005-12-05 2008-10-07 Sontra Medical Corporation Biocompatible chemically crosslinked hydrogels for glucose sensing
US9572527B2 (en) 2007-04-27 2017-02-21 Echo Therapeutics, Inc. Skin permeation device for analyte sensing or transdermal drug delivery

Also Published As

Publication number Publication date
WO1990015568A2 (fr) 1990-12-27
AU5825490A (en) 1991-01-08
KR920700014A (ko) 1992-02-19

Similar Documents

Publication Publication Date Title
WO1990015568A3 (fr) Appareil et methodes pour le controle non-invasif du glucose dans le sang
US6904301B2 (en) Micro-invasive method for painless detection of analytes in extracellular space
WO2003087775A3 (fr) Procede et dispositif permettant une surveillance non effractive des substances presentes dans le sang par l'utilisation de larmes auto-prelevees
EA199900145A1 (ru) Неинвазивный непрерывный контроль за уровнем глюкозы в крови
ATE286675T1 (de) Gerät zur entnahme von interstitiellen flüssigkeit für diagnostische teste
CA2174719A1 (fr) Systeme de mesure, non invasif, precis et robuste, pour substance a analyser
IL91874A0 (en) Device for piercing a tissue of a living being for acquiring a liquid sample,liquid analyte sensor and methods for using same
WO1998024366A3 (fr) Procede et dispositif pour prelever du sang en vue d'essais diagnostiques
CA2298856A1 (fr) Equivalents de tissu vivant
AU582511B2 (en) Blood sampling unit
AU657486B2 (en) Visual blood glucose concentration test strip
EP0248670A3 (fr) Système de dialyse
AU4499889A (en) Methods and apparatus for obtaining arterial blood samples
HU902407D0 (en) Process and device for determining components of fluid sample
GB8814496D0 (en) Blood pressure monitoring method & apparatus
AU7850191A (en) Method and apparatus for monitoring blood analytes noninvasively by pulsatile photoplethysmography
GB8821381D0 (en) Blood pressure monitoring method & apparatus
ATE343346T1 (de) Vorrichtung zur überprüfung der genauigkeit eines spektralanalysators
WO2002064024A3 (fr) Interpretation automatique en temps reel d'ondes du cerveau
DE69635075D1 (de) System zur überwachung des blutglucosespiegels
AU2944889A (en) Apparatus for determination of the coagulation time of a blood sample
MX6947E (es) Procedimiento para la preparacion de un concentrado de los factores de coagulacion ix y x de la sangre
EP0158190A3 (en) Test strip for executing daily blood sugar profiles and method for its production and use
WO1996008992A3 (fr) Dispositif et procede d'analyse en fonction du temps du spectre de puissance de signaux physiologiques
CA2051885A1 (fr) Appareil pour mesurer les liquides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP KR

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP KR

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE

NENP Non-entry into the national phase

Ref country code: CA